Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
This study has been completed.
Information provided by (Responsible Party):
First received: June 14, 2011
Last updated: August 29, 2011
Last verified: August 2011
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.|
Further study details as provided by AstraZeneca:
Contacts and Locations
No Contacts or Locations Provided